Removal of transition metals and ammonium from human IVF culture system by an inorganic ion exchanger in the form of a zeolite block packed in gelatine will improve the health and quality of cultured human embryos.
ID
Bron
Verkorte titel
Aandoening
In vitro fertilisation, human embryo, embryo culture, ammonium, transition metals
Ondersteuning
M. Nijs, GIFT, Genk and Herbert M, LIFE, Newcastle.
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Embryo quality (quality and cell number in embryo) and clinical pregnancy rate.
Achtergrond van het onderzoek
The presence of ammonium in human embryo culture medium has a negative effect on embryo physiology and biochemistry. Ammonium concentration will increase due to spontaneous degradation of amino acids as well as by the metabolism of the embryo. Traces of transition metals like copper or iron can have a detrimental effect on embryo development as well. Removal of these embryo-toxic elements during embryo culture could improve the health and quality of the human embryo.
Tramm-ex is a zeolite block with cross linked gelatin and is an inorganic ion exchanger. Laboratory test have shown that Tramm-ex removes 50% of the ammonium content as well as a factor 100.000 of the transition metals from culture medium. Zeolite has no negative effect on mouse embryo development. The sperm survival test did not identify the Tramm-ex blocks as embryotoxic. In this prospective randomised study, human embryos will be cultured with and without Tramm-ex. Embryo quality and health as well as clinical pregnancy rates will be evaluated.
Doel van het onderzoek
Removal of transition metals and ammonium from human IVF culture system by an inorganic ion exchanger in the form of a zeolite block packed in gelatine will improve the health and quality of cultured human embryos.
Onderzoeksopzet
Embryo quality (during the 5-day embryo culture) and clinical pregnancy rate (12 days and 6 weeks after embryo transfer).
Onderzoeksproduct en/of interventie
Embryo culture will be performed with or without the inorganic ionexchanger Tramm-ex. The randomisation is performed by ‘the research randomizer’ on 100 consecutive patients undergoing IVF/ICSI treatment in each centre. Each centre receives a list for randomisation. Randomisation is performed at the time of check for fertilisation. Embryo scoring and selection for transfer and/or cryopreservation is done according to standard methods. Single embryo transfer from either culture system is done on day 3, 4 or 5.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients entering the IVF/ICSI program.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. ICSI cases for preimplantation genetic diagnosis;
2. ICSI cases with testicular spermatozoa.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1511 |
NTR-old | NTR1581 |
Ander register | intern : GIFTNFC2009-1 |
ISRCTN | ISRCTN wordt niet meer aangevraagd |